Last Updated: November 5, 2026

Patent: 10,842,867

✉ Email this page to a colleague

Summary for Patent: 10,842,867

Title:	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
Abstract:	An immunogenic composition comprising (i) a non-virion influenza virus antigen prepared from a virus grown in cell culture; and (ii) an adjuvant. Preferred adjuvants comprise oil-in-water emulsions.
Inventor(s):	Rino Rappuoli, Derek O'Hagan, Giuseppe Del Giudice
Assignee:	Seqirus UK Ltd
Application Number:	US12/092,325
Patent Claims:	see list of patent claims

Details for Patent 10,842,867

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Auxilium Pharmaceuticals, Inc.	XIAFLEX	collagenase clostridium histolyticum	For Injection	125338	February 2, 2010	10,842,867	2026-11-06
Seqirus Inc.	AUDENZ	influenza a (h5n1) monovalent vaccine, adjuvanted	Injection	125692	January 31, 2020	10,842,867	2026-11-06
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,842,867

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Austria	E513561	⤷ Start Trial
Austria	E539765	⤷ Start Trial
Australia	2006310163	⤷ Start Trial
Australia	2006310246	⤷ Start Trial
Australia	2006310336	⤷ Start Trial
Australia	2006310337	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.